Home/Filings/4/0000930413-21-000039
4//SEC Filing

RABBANI ELAZAR 4

Accession 0000930413-21-000039

CIK 0000316253other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 9:40 PM ET

Size

5.3 KB

Accession

0000930413-21-000039

Insider Transaction Report

Form 4
Period: 2021-01-11
RABBANI ELAZAR
DirectorChairman and CEO
Transactions
  • Award

    Common Stock, par value $0.01 per share

    2021-01-11+190,1142,262,208 total
Footnotes (2)
  • [F1]The shares of Common Stock were issued in lieu of a previously announced cash bonus of $500,000 for Dr. Rabbani for the fiscal year ended July 31, 2020 pursuant to Dr. Rabbani's request to accept shares of Common Stock in lieu of the cash bonus, based on the closing price of the Common Stock on the New York Stock Exchange of $2.63 per share on January 11, 2021.
  • [F2]Includes (i) 1,792,868 shares of Common Stock held by Dr. Rabbani, (ii) 402,050 shares of Common Stock issuable upon the exercise of options which are exercisable within 60 days from the date hereof, (iii) 5,308 shares of Common Stock held in the name of Dr. Rabbani as custodian for certain of his children, (iv) 18,794 shares of Common Stock held in the name of Dr. Rabbani's wife as custodian for certain of their children, and (v) 43,188 shares of Common Stock held in the Company's 401(k) plan.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0000903568

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:40 PM ET
Size
5.3 KB